Cochlear Limited CHEOY

Company Overview

Cochlear Limited is an Australian medical device company specializing in implantable hearing solutions for people with moderate to profound hearing loss. The company operates primarily in the global hearing healthcare and medical technology industries, with a core focus on cochlear implants, bone conduction implants, and acoustic implant technologies. Cochlear generates most of its revenue through the sale of implant systems, sound processors, upgrade services, accessories, and ongoing clinical support programs. Its customer base includes hospitals, audiology clinics, hearing specialists, governments, and individual recipients across both developed and emerging healthcare markets.

The company is widely recognized for its leadership position in cochlear implant technology and for maintaining one of the largest installed recipient bases globally. Cochlear’s competitive positioning is supported by long-term investment in research and development, extensive clinical evidence, regulatory approvals across major jurisdictions, and close relationships with surgeons and hearing healthcare professionals. Founded in 1981 following technology developed by Professor Graeme Clark at the University of Melbourne, the company evolved from early commercialization of multi-channel cochlear implant technology into a globally diversified hearing implant manufacturer listed on the Australian Securities Exchange.